发明名称 |
Cell populations which co-express CD49C and CD90 |
摘要 |
<p>Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made by selecting from a cultured source of a cell population which co-expresses CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and to formulate pharmaceutical compositions. In a further embodiment, a substantially homogenous populaton of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.</p> |
申请公布号 |
AU2009208096(B2) |
申请公布日期 |
2013.01.24 |
申请号 |
AU20090208096 |
申请日期 |
2009.08.11 |
申请人 |
GARNET BIOTHERAPEUTICS, INC. |
发明人 |
HO, TONY W.;KOPEN, GENE C.;RIGHTER, WILLIAM F.;RUTKOWSKI, J. LYNN;HERRING, W. JOSEPH;RAGAGLIA, VANESSA;WAGNER, JOSEPH |
分类号 |
C12N15/09;A61K35/12;A61K35/28;A61K35/34;A61K35/36;A61K35/44;A61K35/50;A61P9/04;A61P9/10;A61P19/08;A61P21/04;A61P25/00;A61P25/16;A61P35/00;C12N5/0775;C12N5/0797 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|